| Similasan AG - Similasan Hypericum, Tabletten | | 56389 | | 01 | | Similasan Hypericum | | Tabletten | | N06AX25 | | Hyperici Herba | | 18.08.2004 | | |
| | Composition | | hypericum perforatum (HAB) D12 (HAB 3a, HAB 7) 8.33 mg, hypericum perforatum (HAB) D15 (HAB 3a, HAB 7) 8.33 mg, hypericum perforatum (HAB) D30 (HAB 3a, HAB 7) 8.33 mg, maydis amylum, magnesii stearas, lactosum monohydricum, pro compresso 250 mg corresp. lactosum monohydricum 241.25 mg. | | Packungsbestandteile | | Tablets | | | | Active Agent | Dose |
|---|
| Hypericum Perforatum (Hab) D12 (Hab 3A, hab 7) | 8.33 mg | | Hypericum Perforatum (Hab) D15 (Hab 3A, hab 7) | 8.33 mg | | Hypericum Perforatum (Hab) D30 (Hab 3A, hab 7) | 8.33 mg |
| | | | Inactive agents | Dose |
|---|
| Lactose Monohydrate | | | Magnesii Stearas | | | Maydis Amylum | | | Pro Compresso | 250 mg |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 80 Tablet(s) | PR | PR | D | | Yes |
|
|
